IRVINE, Calif.--(BUSINESS WIRE)--Diality, a medical device company offering the Moda-flx Hemodialysis System™, today announced that it has joined Kidney Care Partners, the nation’s leading kidney care multi-stakeholder coalition representing patient advocates, physician organizations, health professional groups, dialysis providers, researchers, and manufacturers. Read the full press release here.

Diality, a medical device company developing a smart, flexible hemodialysis platform, today announced that it has secured 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its Moda-flx Hemodialysis System™. Read the full press release here.

IRVINE, Calif.--(BUSINESS WIRE)--Diality Inc. today announced that it will introduce its Moda-flx Hemodialysis System™ at ASN Kidney Week 2023, Nov. 1-5 at the Pennsylvania Convention Center in Philadelphia. The technology will also be the subject of a poster session titled “Blood Flowrate Accuracy with Diality Hemodialysis System” [SA-P0618] to be presented from 10 a.m. to noon on Saturday, Nov. 4 in the exhibit hall. Read the full press release here.

IRVINE, Calif. – May 31, 2023 – Diality Inc., a medical technology company developing a smart, flexible hemodialysis platform, today announced the appointment of healthcare veteran Robert Funari to its board of directors. Funari has spent nearly 50 years in the healthcare industry in public and privately held companies, in both services and medical devices. Read the full press release here.

IRVINE, Calif., March 28, 2022 /PRNewswire/ -- Medical device startup, Diality, Inc. announced it had reached an agreement and partnership with Paramit Corporation for the upcoming manufacture of Diality's versatile hemodialysis system… Read the full press release here.

IRVINE, Calif., March 2, 2022 /PRNewswire/ -- Diality, Inc., a medical device company that is developing a versatile hemodialysis system to address the unmet technology needs of the evolving dialysis industry, announced the close of a $24 million Series B2 investment round… Read the full press release here.

IRVINE, Calif., Aug. 30, 2021 /PRNewswire/ -- Diality Inc. officially announced the addition of Dr. Nissenson to its board of directors. A widely acknowledged expert in kidney disease, Dr. Nissenson is Emeritus Professor of Medicine at the David Geffen School of Medicine at UCLA where he also served as both associate dean and the director of the dialysis program. He was Chief Medical Officer for DaVita Kidney Care for over 11 years and now serves as emeritus chief medical officer... Read the full press release here.

IRVINE, Calif., July 6, 2021 /PRNewswire/ -- Medical device startup Diality announced Dan Guthrie would become the newest member of its executive team, serving as Chief Business Officer effective July 1... Read the full press release here.